These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 16188972)

  • 21. Antibodies to the envelope glycoprotein of human T cell leukemia virus type 1 robustly activate cell-mediated cytotoxic responses and directly neutralize viral infectivity at multiple steps of the entry process.
    Kuo CW; Mirsaliotis A; Brighty DW
    J Immunol; 2011 Jul; 187(1):361-71. PubMed ID: 21646298
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interaction between the HTLV-1 envelope and cellular proteins: impact on virus infection and restriction.
    Ilinskaya A; Heidecker G; Jones K
    Future Med Chem; 2010 Nov; 2(11):1651-68. PubMed ID: 21428837
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CRM1, an RNA transporter, is a major species-specific restriction factor of human T cell leukemia virus type 1 (HTLV-1) in rat cells.
    Zhang X; Hakata Y; Tanaka Y; Shida H
    Microbes Infect; 2006 Mar; 8(3):851-9. PubMed ID: 16504563
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Envelope is a major viral determinant of the distinct in vitro cellular transformation tropism of human T-cell leukemia virus type 1 (HTLV-1) and HTLV-2.
    Xie L; Green PL
    J Virol; 2005 Dec; 79(23):14536-45. PubMed ID: 16282453
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Factors that increase the effective concentration of CXCR4 dictate feline immunodeficiency virus tropism and kinetics of replication.
    de Parseval A; Ngo S; Sun P; Elder JH
    J Virol; 2004 Sep; 78(17):9132-43. PubMed ID: 15308709
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Small noncoding RNAs in cells transformed by human T-cell leukemia virus type 1: a role for a tRNA fragment as a primer for reverse transcriptase.
    Ruggero K; Guffanti A; Corradin A; Sharma VK; De Bellis G; Corti G; Grassi A; Zanovello P; Bronte V; Ciminale V; D'Agostino DM
    J Virol; 2014 Apr; 88(7):3612-22. PubMed ID: 24403582
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro cellular tropism of human T cell leukemia virus type 2.
    Wang TG; Ye J; Lairmore MD; Green PL
    AIDS Res Hum Retroviruses; 2000 Nov; 16(16):1661-8. PubMed ID: 11080807
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Spread of HTLV-I between lymphocytes by virus-induced polarization of the cytoskeleton.
    Igakura T; Stinchcombe JC; Goon PK; Taylor GP; Weber JN; Griffiths GM; Tanaka Y; Osame M; Bangham CR
    Science; 2003 Mar; 299(5613):1713-6. PubMed ID: 12589003
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dendritic Cells Promote the Spread of Human T-Cell Leukemia Virus Type 1 via Bidirectional Interactions with CD4
    Shimauchi T; Caucheteux S; Finsterbusch K; Turpin J; Blanchet F; Ladell K; Triantafilou K; Czubala M; Tatsuno K; Easter T; Ahmed Z; Bayliss R; Hakobyan S; Price DA; Tokura Y; Piguet V
    J Invest Dermatol; 2019 Jan; 139(1):157-166. PubMed ID: 30048652
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Emerging Roles of Heparan Sulfate Proteoglycans in Viral Pathogenesis.
    Koganti R; Memon A; Shukla D
    Semin Thromb Hemost; 2021 Apr; 47(3):283-294. PubMed ID: 33851373
    [TBL] [Abstract][Full Text] [Related]  

  • 31. APOBEC3G targets human T-cell leukemia virus type 1.
    Sasada A; Takaori-Kondo A; Shirakawa K; Kobayashi M; Abudu A; Hishizawa M; Imada K; Tanaka Y; Uchiyama T
    Retrovirology; 2005 May; 2():32. PubMed ID: 15943885
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Repression of human T-cell leukemia virus type 1 and type 2 replication by a viral mRNA-encoded posttranscriptional regulator.
    Younis I; Khair L; Dundr M; Lairmore MD; Franchini G; Green PL
    J Virol; 2004 Oct; 78(20):11077-83. PubMed ID: 15452228
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Virological and immunological mechanisms in the pathogenesis of human T-cell leukemia virus type 1.
    Satou Y; Matsuoka M
    Rev Med Virol; 2013 Sep; 23(5):269-80. PubMed ID: 23606621
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tropical spastic paraparesis and HTLV-1 associated myelopathy: clinical, epidemiological, virological and therapeutic aspects.
    Gessain A; Mahieux R
    Rev Neurol (Paris); 2012 Mar; 168(3):257-69. PubMed ID: 22405461
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Infection of CD4+ T lymphocytes by the human T cell leukemia virus type 1 is mediated by the glucose transporter GLUT-1: evidence using antibodies specific to the receptor's large extracellular domain.
    Jin Q; Agrawal L; VanHorn-Ali Z; Alkhatib G
    Virology; 2006 May; 349(1):184-96. PubMed ID: 16519917
    [TBL] [Abstract][Full Text] [Related]  

  • 36. c-Maf suppresses human T-cell leukemia virus type 1 Tax by competing for CREB-binding protein.
    Hieshima K; Nagakubo D; Shigeta A; Tanaka Y; Hoshino H; Tsukasaki K; Yamada Y; Yoshie O
    Cancer Sci; 2011 Apr; 102(4):890-4. PubMed ID: 21244576
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Majority of interferon-gamma-producing CD4+ cells in patients infected with human T cell lymphotrophic virus do not express tax protein.
    Mitre E; Thompson RW; Carvalho EM; Nutman TB; Neva FA
    J Infect Dis; 2003 Aug; 188(3):428-32. PubMed ID: 12870125
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heparan sulfate proteoglycans are required for cellular binding of the hepatitis E virus ORF2 capsid protein and for viral infection.
    Kalia M; Chandra V; Rahman SA; Sehgal D; Jameel S
    J Virol; 2009 Dec; 83(24):12714-24. PubMed ID: 19812150
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chondroitin Sulfate Proteoglycans Are De Facto Cellular Receptors for Human Papillomavirus 16 under High Serum Conditions.
    Fons NR; Kines RC; Thompson CD; Day PM; Lowy DR; Schiller JT
    J Virol; 2022 Apr; 96(7):e0185721. PubMed ID: 35285688
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A tax on luxury: HTLV-I infection of CD4+CD25+ Tregs.
    Fujinami RS
    J Clin Invest; 2005 May; 115(5):1144-6. PubMed ID: 15864345
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.